These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28991713)

  • 21. A novel pathogenic CACNA1A variant causing episodic ataxia type 2 (EA2) spectrum phenotype in four family members and a novel combined therapy.
    Penkava J; Ledderose S; Chahrokh-Zadeh S; Munzig A; Eulenburg Z; Huppert D; Strupp M; Becker-Bense S
    J Neurol; 2020 Dec; 267(Suppl 1):181-184. PubMed ID: 32910250
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
    Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
    Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel missense variant of CACNA1A gene in a Slovak family with episodic ataxia type 2.
    Petrovicova A; Brozman M; Kurca E; Gobo T; Dluha J; Kalmarova K; Nosal V; Hikkelova M; Krajciova A; Burjanivova T; Sivak S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):107-110. PubMed ID: 28096552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smooth pursuit eye movement deficits after pontine nuclei lesions in humans.
    Gaymard B; Pierrot-Deseilligny C; Rivaud S; Velut S
    J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):799-807. PubMed ID: 8331357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deconstructing speech alterations in episodic ataxia type 2: Perceptual-acoustic analysis in a case due to CACNA1A gene mutation.
    Argenziano G; Cavallieri F; Monfrini E; Gessani A; Russo M; Rizzi R; Fioravanti V; Grisanti S; Toschi G; Napoli M; Pascarella R; Budriesi C; Di Fonzo A; Zucco R; Valzania F
    Parkinsonism Relat Disord; 2023 Mar; 108():105311. PubMed ID: 36805178
    [No Abstract]   [Full Text] [Related]  

  • 26. A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine.
    Ahuja AS; Rozen TD; Atwal PS
    BMC Neurol; 2019 Oct; 19(1):246. PubMed ID: 31640633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive cerebellar ataxia with variable episodic symptoms--phenotypic diversity of R1668W CACNA1A mutation.
    Marti S; Baloh RW; Jen JC; Straumann D; Jung HH
    Eur Neurol; 2008; 60(1):16-20. PubMed ID: 18437043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
    Claassen J; Teufel J; Kalla R; Spiegel R; Strupp M
    J Neurol; 2013 Feb; 260(2):668-9. PubMed ID: 23183922
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports.
    Na S; Kim T
    Neurol Sci; 2021 Sep; 42(9):3897-3899. PubMed ID: 34085110
    [No Abstract]   [Full Text] [Related]  

  • 30. CACNA1A nonsense mutation is associated with basilar-type migraine and episodic ataxia type 2.
    Robbins MS; Lipton RB; Laureta EC; Grosberg BM
    Headache; 2009 Jul; 49(7):1042-6. PubMed ID: 19486177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eye movement disorders are an early manifestation of CACNA1A mutations in children.
    Tantsis EM; Gill D; Griffiths L; Gupta S; Lawson J; Maksemous N; Ouvrier R; Riant F; Smith R; Troedson C; Webster R; Menezes MP
    Dev Med Child Neurol; 2016 Jun; 58(6):639-44. PubMed ID: 26814174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2.
    Choi KD; Yook JW; Kim MJ; Kim HS; Park YE; Kim JS; Choi JH; Shin JH; Kim DS
    Neurol Sci; 2013 Sep; 34(9):1629-32. PubMed ID: 23344743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia.
    Sintas C; Carreño O; Fernàndez-Castillo N; Corominas R; Vila-Pueyo M; Toma C; Cuenca-León E; Barroeta I; Roig C; Volpini V; Macaya A; Cormand B
    Sci Rep; 2017 May; 7(1):2514. PubMed ID: 28566750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of episodic ataxia.
    Jen JC; Baloh RW
    Adv Neurol; 2002; 89():459-61. PubMed ID: 11968470
    [No Abstract]   [Full Text] [Related]  

  • 35. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.
    Yue Q; Jen JC; Thwe MM; Nelson SF; Baloh RW
    Am J Med Genet; 1998 May; 77(4):298-301. PubMed ID: 9600739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of smooth pursuit in pontine lesions: functional topography based on MRI and neuropathologic findings.
    Deleu D; Michotte A; Ebinger G
    Acta Neurol Belg; 1997 Mar; 97(1):28-35. PubMed ID: 9107342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
    García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
    J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics.
    Wan J; Khanna R; Sandusky M; Papazian DM; Jen JC; Baloh RW
    Neurology; 2005 Jun; 64(12):2090-7. PubMed ID: 15985579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures.
    Tokuda S; Kuramoto T; Tanaka K; Kaneko S; Takeuchi IK; Sasa M; Serikawa T
    Brain Res; 2007 Feb; 1133(1):168-77. PubMed ID: 17196942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.
    Spacey SD; Hildebrand ME; Materek LA; Bird TD; Snutch TP
    Ann Neurol; 2004 Aug; 56(2):213-20. PubMed ID: 15293273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.